Catalent Invests $5.5 Million to Increase Clinical Storage Capacity at its Philadelphia Site
SOMERSET, N.J.-September 15, 2017
-Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced that it is investing $5.5 million at its 200,000+ square foot Philadelphia, Pennsylvania site to provide additional clinical packaging and storage capacity. The 22,000-square foot expansion will see a 40 percent increase in pallet space for both refrigerated and ambient storage, the addition of multiple cold chain packaging areas, and a new clinical label control area. The building will also feature a new state-of-the-art environmental monitoring and building management system which is being installed across the Philadelphia campus. All work is scheduled to be completed and validated by November 2017. “This project involved renovating a previously vacant building within our Philadelphia campus to bring it up to Catalent’s stringent facility standards,” commented Wetteny Joseph, Catalent’s President, Clinical Supply Services. “Not only have we added significant pallet capacity for our customers’ large-scale clinical studies today, but have secured the space necessary for future expansion as well.” Catalent currently supports the clinical trial supply needs of many pharmaceutical and biopharmaceutical organizations, including the top 25 pharmaceutical companies, and more than 300 small innovators from all over the world. Services include direct comparator sourcing, blinding and manufacturing, primary and secondary packaging, returns and clinical supplies management.
About Catalent
Catalent is a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 10,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2017 generated over $2 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit
www.catalent.com
More products. Better treatments. Reliably supplied.™
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
